CLO24-079: Results From Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion Dependent (RBC-TD) Non-del(5q) Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents (ESAs)

Authors:
Yazan Madanat Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX

Search for other papers by Yazan Madanat in
Current site
Google Scholar
PubMed Close
 MD
,
Michael R. Savona Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN

Search for other papers by Michael R. Savona in
Current site
Google Scholar
PubMed Close
 MD
,
Mikkael A. Sekeres Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Search for other papers by Mikkael A. Sekeres in
Current site
Google Scholar
PubMed Close
 MD
,
Uwe Platzbecker Leipzig University Hospital, Leipzig, Germany

Search for other papers by Uwe Platzbecker in
Current site
Google Scholar
PubMed Close
 MD
,
Valeria Santini University of Florence, Florence, Italy

Search for other papers by Valeria Santini in
Current site
Google Scholar
PubMed Close
 MD
,
Pierre Fenaux Hôpital Saint-Louis, Université de Paris 7, Paris, France

Search for other papers by Pierre Fenaux in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
Maria Diez-Campelo University Hospital of Salamanca, Salamanca, Spain

Search for other papers by Maria Diez-Campelo in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
David Valcárcel Hospital Universitari Vall d'Hebron, Barcelona, Spain

Search for other papers by David Valcárcel in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
Tymara Berry Geron Corporation, Menlo Park, CA

Search for other papers by Tymara Berry in
Current site
Google Scholar
PubMed Close
 MD
,
Souria Dougherty Geron Corporation, Menlo Park, CA

Search for other papers by Souria Dougherty in
Current site
Google Scholar
PubMed Close
 MBA
,
Sheetal Shah Geron Corporation, Menlo Park, CA

Search for other papers by Sheetal Shah in
Current site
Google Scholar
PubMed Close
 BA
,
Libo Sun Geron Corporation, Menlo Park, CA

Search for other papers by Libo Sun in
Current site
Google Scholar
PubMed Close
 PhD
,
Ying Wan Geron Corporation, Menlo Park, CA

Search for other papers by Ying Wan in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
Fei Huang Geron Corporation, Menlo Park, CA

Search for other papers by Fei Huang in
Current site
Google Scholar
PubMed Close
 PhD
,
Shyamala Navada Geron Corporation, Menlo Park, CA

Search for other papers by Shyamala Navada in
Current site
Google Scholar
PubMed Close
 MD
,
Rami S. Komrokji Moffitt Cancer Center, Tampa, FL

Search for other papers by Rami S. Komrokji in
Current site
Google Scholar
PubMed Close
 MD
, and
Amer M. Zeidan Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT

Search for other papers by Amer M. Zeidan in
Current site
Google Scholar
PubMed Close
 MBBS, MHS
Volume/Issue:
Volume 22: Issue 2.5
Online Publication Date:
05 Apr 2024
DOI:
https://doi.org/10.6004/jnccn.2023.7228
Restricted access
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2024 by the National Comprehensive Cancer Network 2024
Article Category:
Abstract
Print Publication Date:
05 Apr 2024
Online Publication Date:
05 Apr 2024

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1269 917 88
PDF Downloads 233 0 0
EPUB Downloads 0 0 0